F. Siegel
Papers
1
Total Citations
2
H-Index
1
About
F. Siegel’s research centers on urologic oncology, with a particular focus on improving surgical outcomes for prostate cancer patients. Their most notable contribution is the design and execution of the PELYCAN study, a landmark randomised controlled adaptive phase III trial that compared a peritoneal flap technique against no flap for preventing lymphocele formation after robotic-assisted radical prostatectomy with pelvic lymph node dissection. This work addresses a critical postoperative complication, offering evidence-based guidance for urologic surgeons. While the 2023 publication has garnered 2 citations to date, its impact is expected to grow as the field adopts its findings. Siegel’s expertise in adaptive trial methodology and robotic surgery positions them as a key figure in advancing minimally invasive urologic care. Their research not only refines surgical techniques but also prioritises patient quality of life, making a tangible difference in clinical practice. For students and researchers, Siegel’s work exemplifies how rigorous trial design can directly translate into improved surgical standards.
Research Focus
Key Achievements
Top Papers
- 1